Capital Bank & Trust’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-60,332
| Closed | -$5.75M | – | 150 |
|
|
2021
Q2 | $5.75M | Buy |
60,332
+10
| +0% | +$954 | 0.07% | 145 |
|
|
2021
Q1 | $6.87M | Sell |
60,322
-315
| -0.5% | -$35.9K | 0.08% | 147 |
|
|
2020
Q4 | $8.39M | Sell |
60,637
-850
| -1% | -$118K | 0.1% | 132 |
|
|
2020
Q3 | $5.05M | Buy |
61,487
+432
| +0.7% | +$35.5K | 0.07% | 136 |
|
|
2020
Q2 | $4.78M | Buy |
61,055
+2,351
| +4% | +$184K | 0.07% | 138 |
|
|
2020
Q1 | $2.61M | Buy |
58,704
+96
| +0.2% | +$4.27K | 0.04% | 158 |
|
|
2019
Q4 | $2.5M | Sell |
58,608
-70,092
| -54% | -$2.99M | 0.03% | 159 |
|
|
2019
Q3 | $5.51M | Sell |
128,700
-34,892
| -21% | -$1.49M | 0.08% | 135 |
|
|
2019
Q2 | $10.3M | Buy |
163,592
+5,326
| +3% | +$337K | 0.13% | 117 |
|
|
2019
Q1 | $10.9M | Buy |
158,266
+37,959
| +32% | +$2.63M | 0.14% | 115 |
|
|
2018
Q4 | $5.23M | Buy |
120,307
+1,348
| +1% | +$58.6K | 0.08% | 134 |
|
|
2018
Q3 | $9.08M | Sell |
118,959
-1,186
| -1% | -$90.5K | 0.11% | 120 |
|
|
2018
Q2 | $9.24M | Buy |
120,145
+720
| +0.6% | +$55.3K | 0.12% | 122 |
|
|
2018
Q1 | $6.09M | Buy |
119,425
+15,284
| +15% | +$779K | 0.08% | 134 |
|
|
2017
Q4 | $4.83M | Sell |
104,141
-17,273
| -14% | -$801K | 0.07% | 138 |
|
|
2017
Q3 | $6.47M | Sell |
121,414
-547
| -0.4% | -$29.1K | 0.08% | 137 |
|
|
2017
Q2 | $7.58M | Buy |
+121,961
| New | +$7.58M | 0.1% | 131 |
|